X为了获得更好的用户体验,请使用火狐、谷歌、360浏览器极速模式或IE8及以上版本的浏览器
关于我们
欢迎来到科易网(仲恺)技术转移协同创新平台,请 登录 | 注册
尊敬的 , 欢迎光临!  [会员中心]  [退出登录]
成果 专家 院校 需求
当前位置: 首页 >  科技成果  > 详细页

[01266595]基于网络表征学习的癌症细胞系药物响应预测方法

交易价格: 面议

所属行业: 网络

类型: 非专利

交易方式: 资料待完善

联系人:

所在地:安徽合肥市

服务承诺
产权明晰
资料保密
对所交付的所有资料进行保密
如实描述
|
收藏
|

技术详细介绍

标题一

这是第一段文字。

这是第二段文字。

标题二

这是第三段文字。

这是第四段文字。

标题三

这是第五段文字。

这是第六段文字。

标题四

这是第七段文字。

这是第八段文字。

标题五

这是第九段文字。

这是第十段文字。

Motivation: Prediction of cancer patient’s response to therapeutic agent is important for personalized treatment. Because experimental verification of reactions between large cohort of patients and drugs is time-intensive, expensive and impractical, preclinical prediction model based on largescale pharmacogenomic of cancer cell line is highly expected.

However, most of the existing computational studies are primarily based on genomic profiles of cancer cell lines while ignoring relationships among genes and failing to capture functional similarity of cell lines.

Results: In this study, we present a novel approach named NRL2DRP, which integrates protein–protein interactions and captures similarity of cell lines’ functional contexts, to predict drug responses. Through integrating genomic aberrations and drug responses information with protein–protein interactions, we construct a large response-related network, where the neighborhood structure of cell line provides a functional context to its therapeutic responses.

Representation vectors of cell lines are extracted through network representation learning method, which could preserve vertices’ neighborhood similarity and serve as features to build predictor for drug responses.

The predictive performance of NRL2DRP is verified by cross-validation on GDSC dataset and methods comparison, where NRL2DRP achieves AUC > 79% for half drugs and outperforms previous methods.

The validity of NRL2DRP is also supported by its effectiveness on uncovering accurate novel relationships between cell lines and drugs. Lots of newly predicted drug responses are confirmed by reported experimental evidences.

标题一

这是第一段文字。

这是第二段文字。

标题二

这是第三段文字。

这是第四段文字。

标题三

这是第五段文字。

这是第六段文字。

标题四

这是第七段文字。

这是第八段文字。

标题五

这是第九段文字。

这是第十段文字。

Motivation: Prediction of cancer patient’s response to therapeutic agent is important for personalized treatment. Because experimental verification of reactions between large cohort of patients and drugs is time-intensive, expensive and impractical, preclinical prediction model based on largescale pharmacogenomic of cancer cell line is highly expected.

However, most of the existing computational studies are primarily based on genomic profiles of cancer cell lines while ignoring relationships among genes and failing to capture functional similarity of cell lines.

Results: In this study, we present a novel approach named NRL2DRP, which integrates protein–protein interactions and captures similarity of cell lines’ functional contexts, to predict drug responses. Through integrating genomic aberrations and drug responses information with protein–protein interactions, we construct a large response-related network, where the neighborhood structure of cell line provides a functional context to its therapeutic responses.

Representation vectors of cell lines are extracted through network representation learning method, which could preserve vertices’ neighborhood similarity and serve as features to build predictor for drug responses.

The predictive performance of NRL2DRP is verified by cross-validation on GDSC dataset and methods comparison, where NRL2DRP achieves AUC > 79% for half drugs and outperforms previous methods.

The validity of NRL2DRP is also supported by its effectiveness on uncovering accurate novel relationships between cell lines and drugs. Lots of newly predicted drug responses are confirmed by reported experimental evidences.

推荐服务:

Copyright © 2015 科易网 版权所有 闽ICP备07063032号-5